View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Niraparib 300 / Bevacizumab 15, Ovarian ca, maintenance
Protocol-ID: 487 V1.1 (Mini), NIRA300/BEVA15, ovarian Ca, maint.Indication(s)
- Ovarian Tumor; ICD-10 C56
Links
- M.R. Mirza et al. A phase 1 study to evaluate the safety and tolerability of bevacizumab-niraparib combination therapy and determine the recommended phase 2 dose (RP2D) in women with platinum-sensitive epithelial ovarian cancer (ENGOT-OV24/AVANOVA1) [DOI]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 08.11.2021